Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06063174Not ApplicableCompleted

Stress & Resilience Study

Role: collaborator

NCT04843332Not ApplicableCompleted

Community Health Workers and Precision Medicine

Role: collaborator

NCT02910037Not ApplicableCompleted

Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort

Role: collaborator

NCT03064360Completed

Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring

Role: collaborator

NCT03349918Not ApplicableCompleted

PERsonal ContExtual Precision healTh

Role: collaborator

All 5 trials loaded